CALSADA CRISPINA (Chief Financial Officer) received a stock award from REGULUS THERAPEUTICS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/17/2024ACC: 0001209191-24-001775
Officer· Chief Financial Officer
Since Aug 2019
+96.25K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
96.25K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+11.25K
Price / share
—
Trade value
—
% of position
New position
1/12/2024
0.00→11.25K
Total
Net shares
+11.25K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/12/2024 | A · Award | +11.25K | — | — | New position | 0.00 | 11.25K |
| Total | +11.25K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
85K shares
Shares
+85K
Strike price
1.30
Held after
85K
Exercisable
—
1/12/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock85K shares | 1/12/2024 | A · Award | +85K | 1.30 | — | 85K |